BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19717164)

  • 1. Voice onset time in Parkinson disease.
    Fischer E; Goberman AM
    J Commun Disord; 2010; 43(1):21-34. PubMed ID: 19717164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication.
    Whitfield JA; Reif A; Goberman AM
    Clin Linguist Phon; 2018; 32(7):587-594. PubMed ID: 29064294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease.
    Goberman AM; Blomgren M
    J Voice; 2008 Mar; 22(2):178-91. PubMed ID: 16950600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Speech and voice disorders in Parkinson's disease].
    Martnez-Sánchez F
    Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of syllable-initial voicing and speaking rate on the temporal characteristics of monosyllabic words.
    Allen JS; Miller JL
    J Acoust Soc Am; 1999 Oct; 106(4 Pt 1):2031-9. PubMed ID: 10530026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polar-phase indices of perioral muscle reciprocity during syllable production in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2017 Dec; 19(6):616-627. PubMed ID: 28425760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing relations in speech and the identification of voice-onset times: a stable perceptual boundary for voicing categories across speaking rates.
    Boucher VJ
    Percept Psychophys; 2002 Jan; 64(1):121-30. PubMed ID: 11916295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
    Skodda S; Grönheit W; Schlegel U
    J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of speech therapy and pharmacological treatments on voice and speech in Parkinson s disease: a review of the literature.
    Schulz GM
    Curr Med Chem; 2002 Jul; 9(14):1359-66. PubMed ID: 12132992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Articulatory movements during vowels in speakers with dysarthria and healthy controls.
    Yunusova Y; Weismer G; Westbury JR; Lindstrom MJ
    J Speech Lang Hear Res; 2008 Jun; 51(3):596-611. PubMed ID: 18506038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of utterance rate and length on the spatiotemporal index in Parkinson's disease.
    Chu SY; Barlow SM; Lee J; Wang J
    Int J Speech Lang Pathol; 2020 Apr; 22(2):141-151. PubMed ID: 31213093
    [No Abstract]   [Full Text] [Related]  

  • 17. Vowel articulation in Parkinson's disease.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Jul; 25(4):467-72. PubMed ID: 20434876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of VOT in Turkish speakers with aphasia.
    Kopkalli-Yavuz H; Mavis I; Akyildiz D
    Clin Linguist Phon; 2011 Apr; 25(4):287-301. PubMed ID: 21091206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voice Use in Daily Life Studied With a Portable Voice Accumulator in Individuals With Parkinson's Disease and Matched Healthy Controls.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Speech Lang Hear Res; 2019 Dec; 62(12):4324-4334. PubMed ID: 31830844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice onset time versus articulatory modeling for stop consonants.
    Rothenberg M
    Logoped Phoniatr Vocol; 2009 Dec; 34(4):171-80. PubMed ID: 19513923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.